On June 19th, Gelonhui reported that Vicom Ltd (301126.SZ) stated on the investor platform that the company owns two pharmaceutical companies, Dakang Biological Pharmaceutical and Tianji Caotang, and has established a pharmaceutical industry system. Currently, the company's pharmaceutical industry business mainly focuses on the layout of Chinese patent medicine products, and conducts production and processing of pharmaceuticals, medical devices, food, etc., as well as pharmaceutical research and development. The company's in-development product Oseltamivir Phosphate syrup has completed CDE declaration, and the clinical BE trial of Atorvastatin Calcium tablets is underway.
达嘉维康(301126.SZ)：医药工业业务主要围绕中成药产品布局，开展药品、器械、食品等的生产加工以及药品研发
Vicom Ltd (301126.SZ): The business of the pharmaceutical industry mainly focuses on the layout of Chinese patent medicine products, conducting the production and processing of pharmaceuticals, medical devices, food, and pharmaceutical research and develo
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.